Skip to main content
LGVN
NASDAQ Life Sciences

Longeveron Receives Nasdaq Extension to Regain Minimum Bid Price Compliance

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$0.966
Mkt Cap
$22.482M
52W Low
$0.475
52W High
$1.9
Market data snapshot near publication time

Summary

Longeveron Inc. received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, pushing the deadline to September 21, 2026.


Key Events

  • Nasdaq Grants Listing Extension

    Longeveron Inc. received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, setting a new deadline of September 21, 2026.

  • No Immediate Delisting

    The notice confirms that there is no immediate effect on the company's continued listing status on The Nasdaq Capital Market.

  • Potential Reverse Stock Split

    The company stated its intention to monitor its stock price and assess options, including a reverse stock split, if necessary, to regain compliance.

  • Ongoing Compliance Challenge

    This follows an initial delisting notice on September 22, 2025, highlighting the company's persistent challenge in meeting Nasdaq's minimum bid price rule amidst broader financial concerns.


Analysis

Longeveron Inc. has been granted an additional 180 days by Nasdaq, extending its compliance period for the $1.00 minimum bid price requirement until September 21, 2026. This extension provides a temporary reprieve from immediate delisting, which is critical for a company that recently disclosed substantial doubt about its ability to continue as a going concern in its 10-K filing on March 17, 2026. While the extension avoids an immediate negative outcome, the company still faces the challenge of raising its stock price, potentially through a reverse stock split, to maintain its Nasdaq listing. This situation underscores the ongoing financial pressures and the need for strategic actions to ensure long-term viability, following a highly dilutive private placement in mid-March.

At the time of this filing, LGVN was trading at $0.97 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.5M. The 52-week trading range was $0.48 to $1.90. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LGVN - Latest Insights

LGVN
Jun 09, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7855
Real-time Price: $0.7826 info
Change: -$0.0029 (-0.37%) info
Market Cap: $24.756M info
LGVN
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.730
Real-time Price: $0.7826 info
Change: +$0.0526 (+7%) info
Market Cap: $24.756M info
LGVN
May 20, 2026, 4:11 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.7826 info
Change: +$0.0026 (+0.33%) info
Market Cap: $24.756M info
LGVN
May 20, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.7826 info
Change: +$0.0026 (+0.33%) info
Market Cap: $24.756M info
LGVN
May 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7697
Real-time Price: $0.7826 info
Change: +$0.0129 (+2%) info
Market Cap: $24.756M info
LGVN
May 08, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.834
Real-time Price: $0.7826 info
Change: -$0.0514 (-6%) info
Market Cap: $24.756M info
LGVN
May 08, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7651
Real-time Price: $0.7826 info
Change: +$0.0175 (+2%) info
Market Cap: $24.756M info
LGVN
May 05, 2026, 5:42 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8561
Real-time Price: $0.7826 info
Change: -$0.0735 (-9%) info
Market Cap: $24.756M info
LGVN
Apr 17, 2026, 4:23 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.13
Real-time Price: $0.7826 info
Change: -$0.3474 (-31%) info
Market Cap: $24.756M info
LGVN
Apr 10, 2026, 4:55 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $0.7826 info
Change: -$0.3378 (-30%) info
Market Cap: $24.756M info